The interaction of CD176 on circulating cancer cells and Galectin-3 expressed on the endothelium of distant organ vessels were found to mediate the initial, rate-limiting stages of hematogenous metastasis in several cancer entities, including breast, prostate, colon and pancreatic carcinomas (41). This evidence concerns the gene LGALS3 and exocrine pancreatic carcinoma.